Beta Drugs (NSE:BETA) Net Margin % : 13.55% (As of Sep. 2024)

Beta Drugs Net Margin % Chart

Beta Drugs Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Net Margin %		Get a 7-Day Free Trial					10.37	10.10	13.51	13.53	12.32

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Net Margin %	Get a 7-Day Free Trial															14.09	12.97	14.07	10.72	13.55

Competitive Comparison of Beta Drugs's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Net Margin % distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Net Margin % falls into.

Beta Drugs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Beta Drugs's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Beta Drugs's Net Margin for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs  (NSE:BETA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Beta Drugs Net Margin % Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description